Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4531 (MIR4531) is a short (20-24 nucleotides) non-coding RNA molecule from the microRNA family, encoded in the human genome. Like other microRNAs, MIR4531 is transcribed as a primary transcript and processed by the Drosha and Dicer ribonucleases to form a mature miRNA. Mature miRNAs such as MIR4531 enter the RNA-induced silencing complex (RISC) to bind complementary sequences in target mRNAs, typically leading to translational repression or mRNA destabilization. While microRNAs have broad roles in regulating gene expression across different tissues and biological contexts, there is currently no published evidence tying MIR4531 to specific biological pathways, disease processes, or clinical utility as a biomarker or drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4531 (MIR4531).